Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
$NVIDIA (NVDA.US)$ has been the standout tech stock of the past year, leading the $NASDAQ 100 Index (.NDX.US)$ in the performance ranking.
$英伟达 (NVDA.US)$ 一直是过去一年的杰出科技股,领先 $纳斯达克100指数 (.NDX.US)$ 在绩效排名中。
The chipmaker giant has seen an astounding 186% surge since the end of May 2023, fueled by skyrocketing demand for chips in artificial intelligence development.
自2023年5月底以来,这家芯片制造商巨头的惊人增长了186%,这得益于人工智能开发中对芯片的需求激增。
Veteran Wall Street investor Ed Yardeni recently coined " Magnificent One" to differentiate Nvidia's extraordinary performance from the Magnificent Seven.
华尔街资深投资人埃德·亚尔德尼最近创造了 “Magnificent One”,以区分Nvidia的非凡表现与壮丽七人组。
To illustrate the magnitude of Nvidia's market value increase, just a year ago, the company was valued at $1 trillion. Today, it boasts a staggering $2.8 trillion valuation, making it the third-largest company in the U.S.
为了说明Nvidia市值增长的幅度,就在一年前,该公司的估值为1万亿美元。如今,它拥有惊人的2.8万亿美元估值,使其成为美国第三大公司。
Nvidia's current value is equal to $Tesla (TSLA.US)$, $Eli Lilly and Co (LLY.US)$, $Broadcom (AVGO.US)$, $Walmart (WMT.US)$ and $MasterCard (MA.US)$ combined.
Nvidia 的当前价值等于 $特斯拉 (TSLA.US)$, $礼来 (LLY.US)$, $博通 (AVGO.US)$, $沃尔玛 (WMT.US)$ 和 $万事达 (MA.US)$ 结合的。
However, Nvidia's spectacular ascent is eclipsed by these seven U.S. stocks, which have more than doubled the chipmaker's impressive returns over the last year.
但是,这七只美国股票使Nvidia的惊人上涨黯然失色,这七只股票使这家芯片制造商去年可观的回报率翻了一番多。
7. $Vera Therapeutics (VERA.US)$: 363%
7。 $Vera Therapeutics (VERA.US)$: 363%
$Vera Therapeutics (VERA.US)$ is a biopharmaceutical company dedicated to developing transformative treatments for serious immunological diseases. The company's stock surged due to advancements in its clinical programs and optimistic projections for its drug candidates.
$Vera Therapeutics (VERA.US)$ 是一家生物制药公司,致力于开发针对严重免疫疾病的变革性治疗方法。由于临床项目的进展以及对候选药物的乐观预测,该公司的股票飙升。
Its 363% surge since May 30, 2023, doubled the performance of Nvidia during the same timeframe.
自2023年5月30日以来,其增长了363%,使英伟达在同一时期的表现翻了一番。
6. $Vertiv Holdings (VRT.US)$: 413%
6。 $Vertiv Holdings (VRT.US)$: 413%
Vertiv Holdings Co. provides critical digital infrastructure and continuity solutions. The company has benefited from the increasing demand for data centers and IT infrastructure, driving robust financial performance and, consequently, a substantial increase in its stock price.
Vertiv Holdings Co. 提供关键的数字基础设施和连续性解决方案。该公司受益于对数据中心和IT基础设施不断增长的需求,推动了强劲的财务业绩,从而实现了股价的大幅上涨。
5. $MicroStrategy (MSTR.US)$: 441%
5。 $MicroStrategy (MSTR.US)$: 441%
MicroStrategy Incorporated is a business intelligence company that has gained substantial attention for its significant investments in $Bitcoin (BTC.CC)$.
MicroStrategy Incorporated是一家商业智能公司,因其在以下方面的重大投资而备受关注 $比特币 (BTC.CC)$。
The company's stock performance is closely tied to Bitcoin's price movements, and its value has soared with the cryptocurrency's rise. The largest cryptocurrency has seen a 140% rise since the end of May 2023.
该公司的股票表现与比特币的价格走势密切相关,其价值随着加密货币的上涨而飙升。自2023年5月底以来,最大的加密货币已上涨140%。
4. $Abercrombie & Fitch (ANF.US)$: 503%
4。 $爱芬奇 (ANF.US)$: 503%
Abercrombie & Fitch is a renowned fashion retailer, known for its casual wear and lifestyle products. The stock's impressive rise is attributed to the company's successful rebranding efforts, strong e-commerce growth and improved profitability metrics, attracting investor interest.
Abercrombie & Fitch是一家著名的时装零售商,以其休闲服装和生活方式产品而闻名。该股的惊人上涨归因于该公司成功的品牌重塑工作、强劲的电子商务增长和盈利指标的改善,吸引了投资者的兴趣。
3. $Carvana (CVNA.US)$: 666%
3。 $Carvana (CVNA.US)$: 666%
Carvana is an online used car retailer that has revolutionized the car buying experience by offering a fully online platform with home delivery and a seven-day return policy.
Carvana是一家在线二手车零售商,通过提供送货上门和七天退货政策的完全在线平台,彻底改变了购车体验。
Its stock skyrocketed as the company continued to recover from a difficult period and investors regained confidence in its unique business model and growth potential.
随着公司继续从困难时期中恢复过来,其股票飙升,投资者对其独特的商业模式和增长潜力恢复了信心。
2. $Soleno Therapeutics (SLNO.US)$: 697%
2。 $Soleno Therapeutics (SLNO.US)$: 697%
Soleno Therapeutics focuses on developing treatments for rare diseases, with a primary emphasis on genetic disorders such as Prader-Willi syndrome. The company's stock has surged due to positive clinical trial results and increased optimism about its pipeline of drug candidates.
Soleno Therapeutics专注于开发罕见疾病的治疗方法,主要侧重于诸如普拉德-威利综合征之类的遗传性疾病。由于临床试验结果良好,以及对其候选药物管道的乐观情绪增加,该公司的股票飙升。
1. $MoneyLion (ML.US)$ 790%
1。 $MoneyLion (ML.US)$ 790%
MoneyLion Inc. is a digital financial platform offering a range of products, including personal loans, credit-building services, and financial advisory tools. Its significant stock surge is driven by aggressive expansion and innovation in fintech services, appealing to a broad customer base looking for accessible financial solutions.
MoneyLion Inc. 是一个数字金融平台,提供一系列产品,包括个人贷款、信用建设服务和财务咨询工具。其股价大幅上涨是由金融科技服务的积极扩张和创新推动的,吸引了寻求无障碍金融解决方案的广泛客户群。